BUY Gland Pharma Limited — Prakash Gaba
byPrakash GabaHorizon: NA (inferred Swing (≤2wk))7 Oct 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
5 advisors have active short-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · adjacent horizon·8 Oct · today
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·6 Oct · yesterday
Gland Pharma to invest $21 million in US drugmaker, take 60% stake
NewsCnbc-Tv18·1 Oct · 6d ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Gland Pharma
- BUY — Kunal Parar, Choice Broking8 Oct 2026 · Same day · target ₹3,235 · Expired
- BUY — Nomura India Research7 Oct 2026 · ~1 year · target ₹3,750 · Active
- BUY — Raja Venkatraman7 Oct 2026 · ~3 months · target ₹3,325 · Active
- BUY — Amit Seth6 Oct 2026 · ~2 weeks · target ₹3,060 · Target hit
- BUY — IDBI Capital6 Oct 2026 · ~2 weeks · target ₹3,210 · Active
More from Prakash Gaba
- BUY Isgec Heavy Engineering8 Oct 2026 · ~2 weeks · target ₹950 · Active
- SELL Muthoot Finance8 Oct 2026 · ~2 weeks · target ₹2,500 · Active
- SELL Tata Steel8 Oct 2026 · Next day · target ₹166 · Active
- BUY Netweb Technologies India8 Oct 2026 · Same day · target ₹4,950 · SL hit
- BUY Tata Consultancy Services8 Oct 2026 · Same day · target ₹2,175 · SL hit

